Acquisition of POEMS syndrome features over time
Patient characteristics . | Initial POEMS features . | Subsequently acquired POEMS features . | TTP, y . | FU, y . | Response to therapy . | Current status . | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. . | Sex . | Age, y . | P . | O . | E . | M . | S . | A . | B, no. . | C . | Pap . | |||||
1 | F | 66 | P | M | Diff | Hypothyroid, hypoadrenal at 126 mo; ascites, pulmonary hypertension at 156 mo | 10.5 | 14.5 | V gd | Alive | ||||||
2 | F | 34 | P | M | 2 or 3 | Ascites, Budd-Chiari at 149 mo; pleural effusion at 156 mo | 12.4 | 13.4 | V gd | Alive | ||||||
3 | F | 34 | P | M | S | Diff | Detectable monoclonal protein in serum at 39 mo; hypothyroid at 60 mo; ascites and hepatomegaly at 87 mo | 5.0 | 7.8 | Stable | Dead | |||||
4 | M | 46 | P | O | M | A | Diff | Pulmonary hypertension and effusion at 36 mo; hypothyroid at 52 mo; acrocyanosis at 54 mo | 3.0 | 5.8 | Good | Alive | ||||
5 | F | 58 | P | M | S | A | Diff | Pap | Hypothyroid at 9 mo; ascites and renal failure at 12 mo | 0.8 | 3.3 | Good | Dead | |||
6 | M | 43 | P | M | S | 2 or 3 | Hypoadrenal at 4 mo | 0.3 | 1.0 | Refr | Alive | |||||
7 | F | 50 | P | M | S | 1 | Pericardial effusion at 1 mo | 0.1 | 0.2 | Refr | Dead | |||||
8 | M | 38 | P | E | M | S | 1 | CHF, hypogonad, hypothyroid, hypoadrenal, peripheral edema, acrocyanosis, hypertrichosis, hyperpigmentation at 192 mo | 16.0 | 16.4 | V gd | Alive | ||||
9 | F | 33 | P | E | M | S | 1 | Pap | Peripheral edema at 90 mo | 7.5 | 9.5 | V gd | Alive | |||
10 | M | 56 | P | E | M | S | 2 or 3 | Diabetes mellitus at 94 mo | 7.8 | 9.1 | V gd | Alive | ||||
11 | F | 44 | P | E | M | S | 1 | Pap | Ascites and CHF at 56 mo | 4.7 | 5.0 | Good | Dead | |||
12 | M | 51 | P | O | M | S | Diff | C | Clubbing, ascites, and renal failure at 52 mo | 4.3 | 4.9 | ND | Dead | |||
13 | F | 61 | P | E | M | S | 2 or 3 | Ascites at 1 mo | 0.1 | 0.7 | ND | Alive | ||||
14 | F | 57 | P | O | E | M | S | A | Diff | Ascites at 22 mo; renal failure and oxygen dependence at 117 mo | 1.8 | 10.0 | V gd | Dead | ||
15 | F | 50 | P | O | E | M | S | 2 or 3 | Pap | Ascites at 12 mo; respiratory failure at 66 mo | 1.0 | 5.7 | Good | Dead | ||
16 | M | 51 | P | O | E | M | S | 2 or 3 | Hepatomegaly and hepatic dysfunction at 30 mo | 2.5 | 2.8 | Good | Dead | |||
17 | M | 39 | P | O | E | M | S | 1 | Lymphadenopathy at 17 mo; restrictive lung disease at 36 mo | 1.4 | 1.4 | Good | Alive | |||
18 | M | 64 | P | O | E | M | S | A | Diff | Pap | Hypoparathyroid at 84 mo | 7.0 | 14.6 | Good | Alive |
Patient characteristics . | Initial POEMS features . | Subsequently acquired POEMS features . | TTP, y . | FU, y . | Response to therapy . | Current status . | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
No. . | Sex . | Age, y . | P . | O . | E . | M . | S . | A . | B, no. . | C . | Pap . | |||||
1 | F | 66 | P | M | Diff | Hypothyroid, hypoadrenal at 126 mo; ascites, pulmonary hypertension at 156 mo | 10.5 | 14.5 | V gd | Alive | ||||||
2 | F | 34 | P | M | 2 or 3 | Ascites, Budd-Chiari at 149 mo; pleural effusion at 156 mo | 12.4 | 13.4 | V gd | Alive | ||||||
3 | F | 34 | P | M | S | Diff | Detectable monoclonal protein in serum at 39 mo; hypothyroid at 60 mo; ascites and hepatomegaly at 87 mo | 5.0 | 7.8 | Stable | Dead | |||||
4 | M | 46 | P | O | M | A | Diff | Pulmonary hypertension and effusion at 36 mo; hypothyroid at 52 mo; acrocyanosis at 54 mo | 3.0 | 5.8 | Good | Alive | ||||
5 | F | 58 | P | M | S | A | Diff | Pap | Hypothyroid at 9 mo; ascites and renal failure at 12 mo | 0.8 | 3.3 | Good | Dead | |||
6 | M | 43 | P | M | S | 2 or 3 | Hypoadrenal at 4 mo | 0.3 | 1.0 | Refr | Alive | |||||
7 | F | 50 | P | M | S | 1 | Pericardial effusion at 1 mo | 0.1 | 0.2 | Refr | Dead | |||||
8 | M | 38 | P | E | M | S | 1 | CHF, hypogonad, hypothyroid, hypoadrenal, peripheral edema, acrocyanosis, hypertrichosis, hyperpigmentation at 192 mo | 16.0 | 16.4 | V gd | Alive | ||||
9 | F | 33 | P | E | M | S | 1 | Pap | Peripheral edema at 90 mo | 7.5 | 9.5 | V gd | Alive | |||
10 | M | 56 | P | E | M | S | 2 or 3 | Diabetes mellitus at 94 mo | 7.8 | 9.1 | V gd | Alive | ||||
11 | F | 44 | P | E | M | S | 1 | Pap | Ascites and CHF at 56 mo | 4.7 | 5.0 | Good | Dead | |||
12 | M | 51 | P | O | M | S | Diff | C | Clubbing, ascites, and renal failure at 52 mo | 4.3 | 4.9 | ND | Dead | |||
13 | F | 61 | P | E | M | S | 2 or 3 | Ascites at 1 mo | 0.1 | 0.7 | ND | Alive | ||||
14 | F | 57 | P | O | E | M | S | A | Diff | Ascites at 22 mo; renal failure and oxygen dependence at 117 mo | 1.8 | 10.0 | V gd | Dead | ||
15 | F | 50 | P | O | E | M | S | 2 or 3 | Pap | Ascites at 12 mo; respiratory failure at 66 mo | 1.0 | 5.7 | Good | Dead | ||
16 | M | 51 | P | O | E | M | S | 2 or 3 | Hepatomegaly and hepatic dysfunction at 30 mo | 2.5 | 2.8 | Good | Dead | |||
17 | M | 39 | P | O | E | M | S | 1 | Lymphadenopathy at 17 mo; restrictive lung disease at 36 mo | 1.4 | 1.4 | Good | Alive | |||
18 | M | 64 | P | O | E | M | S | A | Diff | Pap | Hypoparathyroid at 84 mo | 7.0 | 14.6 | Good | Alive |
A indicates anasarca, edema, ascites, or pleural effusion; B, bone lesions; C, Castleman disease; CHF, congestive heart failure; Diff, diffuse; E, endocrinopathy; FU, follow-up; M, monoclonal plasma cell dyscrasia; ND, no data; O, organomegaly (including hepatomegaly, splenomegaly, and lymphadenopathy); P, peripheral neuropathy; Pap, papilledema; Refr, refractory disease; S, skin changes; TTP, time to progression; and V gd, very good.